Janoshik · Supplied sample report

Retatrutide COA and test report #244383

Sample RT30 · 30 mg catalog specification · Batch BPS 581

Verified against the issuer record on 17 Nov 2026. Applies to this sample and batch only.

Original supplied Janoshik Retatrutide test report #244383
Open the original report to inspect every field at full resolution.
Download original report image →

As printed on the supplied report

Sample and test record

Report number
#244383
Sample
Retatrutide RT30
Batch
BPS 581
Client
biopepsynlab.com
Manufacturer field
BioPepSynLab
Testing ordered
16 Oct 2026
Sample received
04 Nov 2026
Analysis conducted
06 Nov 2026

Reported results

Common GLP-1 peptide blind test (Semaglutide, Tirzepatide and Retatrutide)
EntryPrinted result
Retatrutide32.02 mg
Purity99.514%

Report comment: No comment printed.

Reading this particular sample

Amount, purity and identity

The requested panel names Semaglutide, Tirzepatide and Retatrutide, while the results row identifies Retatrutide at 32.02 mg. This does not describe a three-compound blend. RT30 corresponds to the 30 mg catalog specification.

Purity is printed separately as 99.514%. This result belongs to sample RT30, batch BPS 581; it should not be assigned to other Retatrutide specifications or to a new order lot.